CellaVision AB (publ)
General ticker "CLVSF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $481.4M (TTM average)
CellaVision AB (publ) does not follow the US Stock Market performance with the rate: -17.2%.
Estimated limits based on current volatility of 0.0%: low 16.83$, high 16.84$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-08, amount 0.26$ (Y1.54%)
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [18.60$, 30.21$]
- 2025-12-31 to 2026-12-31 estimated range: [17.74$, 29.28$]
Financial Metrics affecting the CLVSF estimates:
- Positive: with PPE of 4.4 at the end of fiscal year the price was low
- Positive: Operating profit margin, % of 24.57 > 18.64
- Positive: Shareholder equity ratio, % of 80.61 > 63.39
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -1.12 <= -0.66
- Positive: 0.33 < Operating cash flow per share per price, % of 2.91
- Positive: Interest expense per share per price, % of 0.03 <= 0.79
Short-term CLVSF quotes
Long-term CLVSF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | SEK639.34MM | SEK677.29MM | SEK723.22MM |
| Operating Expenses | SEK481.07MM | SEK510.24MM | SEK545.54MM |
| Operating Income | SEK158.27MM | SEK167.05MM | SEK177.68MM |
| Non-Operating Income | SEK-9.84MM | SEK-2.83MM | SEK-0.82MM |
| Interest Expense | SEK2.34MM | SEK3.26MM | SEK1.89MM |
| R&D Expense | SEK88.55MM | SEK83.33MM | SEK87.45MM |
| Income(Loss) | SEK148.43MM | SEK164.22MM | SEK176.86MM |
| Taxes | SEK0.00MM | SEK33.91MM | SEK0.00MM |
| Profit(Loss)* | SEK118.33MM | SEK130.31MM | SEK140.72MM |
| Stockholders Equity | SEK641.63MM | SEK716.39MM | SEK815.73MM |
| Inventory | SEK142.57MM | SEK126.04MM | SEK124.82MM |
| Assets | SEK891.75MM | SEK928.71MM | SEK1,011.89MM |
| Operating Cash Flow | SEK137.28MM | SEK196.44MM | SEK198.44MM |
| Capital expenditure | SEK69.43MM | SEK86.48MM | SEK77.75MM |
| Investing Cash Flow | SEK-70.01MM | SEK-85.53MM | SEK-76.01MM |
| Financing Cash Flow | SEK-90.41MM | SEK-97.04MM | SEK-95.09MM |
| Earnings Per Share** | SEK4.96 | SEK5.46 | SEK5.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.